Yale Cancer Center
Personalized vaccine induces durable immune response in advanced kidney cancer
A personalized vaccine demonstrated the potential to induce long-lasting immune response among people with advanced kidney cancer, according to results of a phase 1 trial.
VIDEO: Immunotherapy may offer next big breakthrough in advanced prostate cancer
In a video interview, William K. Oh, MD, director of precision medicine at Yale Cancer Center and Smilow Cancer Hospital discusses the latest breakthroughs in advanced prostate cancer treatment.
VIDEO: New targets sought for advanced prostate cancer treatment
In a video interview, William K. Oh, MD, director of precision medicine at Yale Cancer Center and Smilow Cancer Hospital discusses the latest breakthroughs in advanced prostate cancer treatment.
VIDEO: PSMA PET imaging 'single most important advance' in advanced prostate cancer
In a video interview, William K. Oh, MD, director of precision medicine at Yale Cancer Center and Smilow Cancer Hospital discusses the latest breakthroughs in advanced prostate cancer treatment.
VIDEO: Androgen receptor pathway inhibitors ‘have transformed’ prostate cancer management
In a video interview, William K. Oh, MD, director of precision medicine at Yale Cancer Center and Smilow Cancer Hospital discusses the latest breakthroughs in advanced prostate cancer treatment.
VIDEO: Upfront use of PARP, ARPI combination may offer greater survival benefit
In a video interview, William K. Oh, MD, director of precision medicine at Yale Cancer Center and Smilow Cancer Hospital discusses the latest breakthroughs in advanced prostate cancer treatment.
Low-dose aspirin reduces colorectal cancer recurrence for patients with PI3K mutations
Low-dose aspirin significantly reduced risk for colorectal cancer recurrence among patients with mutations in the PI3K pathway, according to results of the randomized ALASCCA study presented at ASCO Gastrointestinal Cancers Symposium.
Blood-based test could increase adherence to colorectal cancer screening
An investigational blood-based test identified nearly 80% of individuals who had colorectal cancer, according to results of a large prospective trial presented at ASCO Gastrointestinal Cancers Symposium.
Higher ferritin threshold cost-effective for diagnosing, treating iron deficiency
SAN DIEGO — A higher ferritin threshold than that used by WHO and CDC is cost-effective for identifying and treating women with iron deficiency, according to study results presented at ASH Annual Meeting and Exposition.
Strategies needed to reduce death due to low-risk breast cancer
Most breast cancer-specific deaths occur among patients diagnosed with stage I or II disease rather than more advanced disease, according to a SEER database analysis.